Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

February 28, 2005

Conditions
Colorectal Cancer
Interventions
DRUG

ZD1839

DRUG

oxaliplatin

Trial Locations (12)

46601

Memorial Hospital of South Bend, South Bend

49085

Oncology Care Associates, P.L.L.C., Saint Joseph

60201

Evanston Northwestern Health Care, Evanston

60426

Ingalls Memorial Hospital, Harvey

60525

LaGrange Memorial Hospital, LaGrange

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

62526

Decatur Memorial Hospital Cancer Care Institute, Decatur

62701

Central Illinois Hematology Oncology Center, Springfield

60637-1470

University of Chicago Cancer Research Center, Chicago

60153-5589

Loyola University Medical Center, Maywood

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00026299 - Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | Biotech Hunter | Biotech Hunter